Literature DB >> 23939178

[Peri-operative management and follow-up outcomes of cardiac surgery in dialysis-dependent patients with end stage renal disease].

Xi-hui Li1, Yan Li, Feng Xiao, Yi-fan Li, Jin Wang, Bo Song, Yang Yang, Shi-yong Dong.   

Abstract

OBJECTIVE: To summarize the perioperative management experience of patients with end-stage renal diseases (ESRD) undergoing cardiac surgery and the follow-up outcomes.
METHODS: From September 2004 to February 2012, 18 dialysis-dependent patients with ESRD received cardiac surgery in Department of Cardiac Surgery, Peking University First Hospital. A series of methods were employed to maintain water-electrolyte and acid-base balance and coagulation function. We followed up the patients by clinic service or telephone.
RESULTS: The spectra of surgical interventions included isolated coronary artery bypass graft (CABG, n=13), isolated valve replacement (VR, n=2) and concomitant CABG and VR (n=3). Of the 18 patients, 3 died within the Peri-operative period and 15 recovered and were discharged. The follow up period was 6-91 months [(27.6±27.5) months]. Within the follow up period, 2 patients died (66th month and 76th month), non-fatal complications occurred in 3 patients. Cardiac functions of the survived patients were good according to the New York Heart Association (NYHA) classification, 4 of them were within NYHA class I and 9 within NYHA class II.
CONCLUSION: Dialysis-dependent patients with end-stage renal diseases are a high risk group receiving cardiac surgery, but a comprehensive Peri-operative management of water-electrolyte and acid-base balance and coagulation function could yield a better outcome.

Entities:  

Mesh:

Year:  2013        PMID: 23939178

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  1 in total

1.  Mitral valve replacement in a dialysis-dependent patient.

Authors:  Ansheng Mo; Zhihu Tao; Zhiqiang Feng; Xiaoping Yang; Jun Wu
Journal:  Ann Transl Med       Date:  2016-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.